Form 8-K - Current report:
SEC Accession No. 0001628280-25-045241
Filing Date
2025-10-16
Accepted
2025-10-16 17:05:37
Documents
13
Period of Report
2025-10-16
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K csbr-20251016.htm   iXBRL 8-K 48164
  Complete submission text file 0001628280-25-045241.txt   177622

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT csbr-20251016.xsd EX-101.SCH 2067
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT csbr-20251016_def.xml EX-101.DEF 4270
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT csbr-20251016_lab.xml EX-101.LAB 23477
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT csbr-20251016_pre.xml EX-101.PRE 14206
15 EXTRACTED XBRL INSTANCE DOCUMENT csbr-20251016_htm.xml XML 2826
Mailing Address 855 N. WOLFE STREET SUITE 619 BALTIMORE MD 21205
Business Address 855 N. WOLFE STREET SUITE 619 BALTIMORE MD 21205 410-369-0365
CHAMPIONS ONCOLOGY, INC. (Filer) CIK: 0000771856 (see all company filings)

EIN.: 521401755 | State of Incorp.: DE | Fiscal Year End: 0430
Type: 8-K | Act: 34 | File No.: 001-11504 | Film No.: 251398301
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)